UKIBCS 2022: Evaluation

UKIBCS 2022 Evaluation

Thank you for taking the time to provide feedback on the UKIBCS 2022.

Question Title

* 1. How would you rate the UKIBCS on-line meeting overall

Excellent

Very good

Good

Average

Poor

Question Title

* 2. Please rate the conference in terms of knowledge gained

Excellent

Very good

Good

Average

Poor

Question Title

* 3. Do you think the programme was well balanced?

Yes

No

If no, please specify:

Question Title

* 4. Please rate the conference sessions you attended

	Excellent	Very good	Good	Average	Poor
Early breast cancer - local treatment	Early breast cancer - local treatment Excellent	Early breast cancer - local treatment Very good	Early breast cancer - local treatment Good	Early breast cancer - local treatment Average	Early breast cancer - local treatment Poor
Early breast cancer - systemic treatment	Early breast cancer - systemic treatment Excellent	Early breast cancer - systemic treatment Very good	Early breast cancer - systemic treatment Good	Early breast cancer - systemic treatment Average	Early breast cancer - systemic treatment Poor
Prevention and early diagnosis	Prevention and early diagnosis Excellent	Prevention and early diagnosis Very good	Prevention and early diagnosis Good	Prevention and early diagnosis Average	Prevention and early diagnosis Poor
Metastatic breast cancer	Metastatic breast cancer Excellent	Metastatic breast cancer Very good	Metastatic breast cancer Good	Metastatic breast cancer Average	Metastatic breast cancer Poor
Industry Symposium: Gilead	Industry Symposium: Gilead Excellent	Industry Symposium: Gilead Very good	Industry Symposium: Gilead Good	Industry Symposium: Gilead Average	Industry Symposium: Gilead Poor
Industry Symposium: Sanofi	Industry Symposium: Sanofi Excellent	Industry Symposium: Sanofi Very good	Industry Symposium: Sanofi Good	Industry Symposium: Sanofi Average	Industry Symposium: Sanofi Poor
Translational/Basic Science	Translational/Basic Science Excellent	Translational/Basic Science Very good	Translational/Basic Science Good	Translational/Basic Science Average	Translational/Basic Science Poor
Living with and beyond breast cancer	Living with and beyond breast cancer Excellent	Living with and beyond breast cancer Very good	Living with and beyond breast cancer Good	Living with and beyond breast cancer Average	Living with and beyond breast cancer Poor
Breast cancer management and research: Our vision for the future	Breast cancer management and research: Our vision for the future Excellent	Breast cancer management and research: Our vision for the future Very good	Breast cancer management and research: Our vision for the future Good	Breast cancer management and research: Our vision for the future Average	Breast cancer management and research: Our vision for the future Poor
Industry Symposium: Lilly	Industry Symposium: Lilly Excellent	Industry Symposium: Lilly Very good	Industry Symposium: Lilly Good	Industry Symposium: Lilly Average	Industry Symposium: Lilly Poor
Industry Symposium: Exact Sciences	Industry Symposium: Exact Sciences Excellent	Industry Symposium: Exact Sciences Very good	Industry Symposium: Exact Sciences Good	Industry Symposium: Exact Sciences Average	Industry Symposium: Exact Sciences Poor

Comments

Question Title

* 5. Would you prefer to attend a virtual or face-to-face meeting for the next UKIBCS

Virtual

Face-to-face

Comments

Question Title

* 6. What topics would you like to suggest for future meetings?

Question Title

* 7. Do you have any other comments on the meeting?